Answers are grounded in this paper and cite their sources.
AMA Socha A, Prokopiuk A, Kornacka A, Babula E, Kołodziejczyk K, Dzierżanowski T. Cardiovascular adverse effects of immune checkpoint inhibitors. Medycyna Paliatywna/Palliative Medicine. 2024;16(1):6-14. doi:10.5114/pm.2024.138609. APA Socha, A., Prokopiuk, A., Kornacka, A., Babula, E., Kołodziejczyk, K., & Dzierżanowski, T. (2024). Cardiovascular adverse effects of immune checkpoint inhibitors. Medycyna Paliatywna/Palliative Medicine, 16(1), 6-14. https://doi.org/10.5114/pm.2024.138609 Chicago Socha, Agnieszka, Agata Prokopiuk, Agata Kornacka, Emilia Babula, Katarzyna Kołodziejczyk, and Tomasz Dzierżanowski. 2024. "Cardiovascular adverse effects of immune checkpoint inhibitors". Medycyna Paliatywna/Palliative Medicine 16 (1): 6-14. doi:10.5114/pm.2024.138609. Harvard Socha, A., Prokopiuk, A., Kornacka, A., Babula, E., Kołodziejczyk, K., and Dzierżanowski, T. (2024). Cardiovascular adverse effects of immune checkpoint inhibitors. Medycyna Paliatywna/Palliative Medicine, 16(1), pp.6-14. https://doi.org/10.5114/pm.2024.138609 MLA Socha, Agnieszka et al. "Cardiovascular adverse effects of immune checkpoint inhibitors." Medycyna Paliatywna/Palliative Medicine, vol. 16, no. 1, 2024, pp. 6-14. doi:10.5114/pm.2024.138609. Vancouver Socha A, Prokopiuk A, Kornacka A, Babula E, Kołodziejczyk K, Dzierżanowski T. Cardiovascular adverse effects of immune checkpoint inhibitors. Medycyna Paliatywna/Palliative Medicine. 2024;16(1):6-14. doi:10.5114/pm.2024.138609.
No takes yet. Share an insight, caveat, or question.
Socha et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: